These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22245566)

  • 1. Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34(+) hematopoietic progenitor cells: use of interleukin-3.
    Demoulin S; Roncarati P; Delvenne P; Hubert P
    Exp Hematol; 2012 Apr; 40(4):268-78. PubMed ID: 22245566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of dendritic cell precursors from human CD34(+) progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome.
    Bontkes HJ; De Gruijl TD; Schuurhuis GJ; Scheper RJ; Meijer CJ; Hooijberg E
    J Leukoc Biol; 2002 Aug; 72(2):321-9. PubMed ID: 12149423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of dendritic cells generated from cord blood CD34+ hematopoietic progenitors in IL-7- and IL-13-conditioned cultures.
    Mytar B; Stec M; Weglarczyk K; Zembala M
    Arch Immunol Ther Exp (Warsz); 2009; 57(1):67-74. PubMed ID: 19219529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors.
    Chen W; Antonenko S; Sederstrom JM; Liang X; Chan AS; Kanzler H; Blom B; Blazar BR; Liu YJ
    Blood; 2004 Apr; 103(7):2547-53. PubMed ID: 14670916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro expansion of CD34+/CD41+ cells from human peripheral blood CD34+/CD41- cells: role of cytokines for in vitro proliferation and differentiation of megakaryocytic progenitors.
    Koizumi K; Sawada K; Yamaguchi M; Notoya A; Tarumi T; Takano H; Fukada Y; Nishio M; Katagiri E; Yasukouchi T; Sato N; Sekiguchi S; Koike T
    Exp Hematol; 1998 Nov; 26(12):1140-7. PubMed ID: 9808053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein 130 and c-kit signals synergistically induce thrombopoietin production by hematopoietic cells.
    Matsui A; Sato T; Maekawa T; Asano S; Nakahata T; Tsuji K
    Int J Hematol; 2000 Dec; 72(4):455-62. PubMed ID: 11197211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells.
    Srivastava AS; Nedelcu E; Esmaeli-Azad B; Mishra R; Carrier E
    Stem Cells; 2007 Jun; 25(6):1456-61. PubMed ID: 17379761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells.
    Rosenzwajg M; Camus S; Guigon M; Gluckman JC
    Exp Hematol; 1998 Jan; 26(1):63-72. PubMed ID: 9430515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.